INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,112 | -12.9% | 8,000 | 0.0% | 0.00% | – |
| Q2 2023 | $3,572 | -45.5% | 8,000 | 0.0% | 0.00% | – |
| Q1 2023 | $6,560 | -47.4% | 8,000 | 0.0% | 0.00% | – |
| Q4 2022 | $12,480 | -10.9% | 8,000 | 0.0% | 0.00% | – |
| Q3 2022 | $14,000 | 0.0% | 8,000 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -51.7% | 8,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $29,000 | -27.5% | 8,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $40,000 | -29.8% | 8,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $57,000 | -65.9% | 8,000 | -55.6% | 0.00% | -66.7% |
| Q2 2021 | $167,000 | +38.0% | 18,000 | +38.5% | 0.00% | 0.0% |
| Q1 2021 | $121,000 | +245.7% | 13,000 | +225.0% | 0.00% | +200.0% |
| Q4 2020 | $35,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Investments Management, LLC | 82,696 | $959,000 | 1.05% |
| Defender Capital, LLC. | 119,914 | $1,391,000 | 0.68% |
| Bayesian Capital Management, LP | 171,200 | $1,986,000 | 0.48% |
| Enlightenment Research, LLC | 13,800 | $160,000 | 0.47% |
| Harvest Investment Services, LLC | 47,558 | $551,000 | 0.32% |
| WASATCH ADVISORS LP | 3,383,001 | $39,243,000 | 0.25% |
| Cedar Brook Financial Partners, LLC | 54,900 | $637,000 | 0.25% |
| Monaco Asset Management SAM | 33,900 | $393,000 | 0.23% |
| Coatue Management | 3,576,923 | $41,492,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 124,884 | $1,449,000 | 0.22% |